Acupuncture for depression and myalgia in patients with hepatitis: an observational study
Zeliha Kocak Tufan1, Hüseyin Arslan, Fatih Yildiz
1Yalikavak Sk 11-2 Manolya Apt, Asagi Eglence, Etlik Ankara 06340, Turkey. drztufan@yahoo.com
Background:
Depressive symptoms and myalgia are commonly seen in patients with chronic hepatitis B and chronic hepatitis C.
Objective:
To investigate the efficacy of acupuncture treatment on depressive symptoms and myalgia in patients with hepatitis.
Methods:
Of 44 patients with hepatitis screened for depression and myalgia, 28 were enrolled and included in the study. The main outcome measure for depressive symptoms was Beck's Depression Inventory (BDI). For pain/myalgia, patients rated their pain on a scale from 0 to 10. Patients with a score greater than the cut-off point in either score were allocated to acupuncture treatment. The Chinese method of acupuncture was used. Treatment continued for 6 weeks.
Results:
At baseline, 17/44 patients (39%) had a BDI score ≥17 and 24 (55%) had a pain score ≥5. A total of 28 patients were allocated to acupuncture treatment, forming three groups: group 1, 13 patients with high BDI and high myalgia scores; group 2, 11 patients with low BDI score but high myalgia score; group 3, 4 patients with high BDI score but low myalgia score. Adherence to treatment was good; all patients completed the sessions and there were no drop-outs. Significant improvements in end-treatment BDI and in myalgia scores compared with baseline levels was found.
Conclusion:
Acupuncture seems to be a promising treatment for patients with hepatitis. Further studies are warranted in large populations to establish the therapeutic role of acupuncture.
